Drug management of adult vascular headaches (migraine and cluster headache): Part II--Prevention and attacks.
D000328:Adult; D000639:Amitriptyline / Q000627:therapeutic use; D001533:Belladonna Alkaloids; D003027:Cluster Headache / Q000517:prevention & control*; D003533:Cyproheptadine / Q000627:therapeutic use; D004338:Drug Combinations / Q000627:therapeutic use; D004878:Ergotamine; D004879:Ergotamines / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008094:Lithium / Q000627:therapeutic use; D016651:Lithium Carbonate; D008297:Male; D008784:Methysergide / Q000627:therapeutic use; D008881:Migraine Disorders / Q000517:prevention & control*; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D009288:Naproxen / Q000627:therapeutic use; D010634:Phenobarbital / Q000627:therapeutic use; D011247:Pregnancy; D011248:Pregnancy Complications / Q000517:prevention & control; D011433:Propranolol / Q000627:therapeutic use; D014653:Vascular Headaches / Q000517:prevention & control*
D001533:Belladonna Alkaloids; D004338:Drug Combinations; D004879:Ergotamines; D008996:Monoamine Oxidase Inhibitors; C044435:belladonna alkaloid, ergotamine, phenobarbital drug combination; D000639:Amitriptyline; D016651:Lithium Carbonate; D003533:Cyproheptadine; D009288:Naproxen; D008094:Lithium; D011433:Propranolol; D004878:Ergotamine; D008784:Methysergide; D010634:Phenobarbital